Anti-cancer drug shows incredible promise in phase 1 human clinical trials
A clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with cancers.
The Brighter Side of News features good news, compassionate news and inspirational news from around the world